"Endostatins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Angiostatic proteins that are formed from proteolytic cleavage of COLLAGEN TYPE XVIII.
| Descriptor ID |
D043169
|
| MeSH Number(s) |
D12.644.276.100.450.750 D12.776.467.100.450.750 D12.776.860.300.250.400.537.500 D23.529.100.450.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Endostatins".
Below are MeSH descriptors whose meaning is more specific than "Endostatins".
This graph shows the total number of publications written about "Endostatins" by people in this website by year, and whether "Endostatins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endostatins" by people in Profiles.
-
Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress. FASEB J. 2017 04; 31(4):1608-1619.
-
An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model. Int Immunopharmacol. 2015 Oct; 28(2):1102-5.
-
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2015 Jan 15; 191(2):208-18.
-
Macrophage elastase suppresses white adipose tissue expansion with cigarette smoking. Am J Respir Cell Mol Biol. 2014 Dec; 51(6):822-9.
-
Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-. Nihon Rinsho Meneki Gakkai Kaishi. 2013; 36(6):452-8.
-
A peptide derived from endostatin ameliorates organ fibrosis. Sci Transl Med. 2012 May 30; 4(136):136ra71.
-
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer. BMC Cancer. 2009 Jan 08; 9:7.
-
Endostatin and anastellin inhibit distinct aspects of the angiogenic process. J Exp Clin Cancer Res. 2008 Nov 04; 27:61.
-
Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther. 2004 Dec; 3(12):1298-303.
-
Endostatin-mediated concomitant resistance in neuroblastoma. J Pediatr Surg. 2004 Mar; 39(3):405-11; discussion 405-11.